The United States holds a substantial portion of the global bladder malignant neoplasm mortality, with a stable growth of 0.12% in 2023. Other countries like Brazil, Poland, and South Korea exhibited notable increases, with growth rates of 2.66%, 2.42%, and 3.94%, respectively. In contrast, countries such as Portugal and Denmark saw declines in mortality share. Emerging trends indicate that Latin American countries like Colombia and Chile are experiencing significant rises in death shares, while European countries showed moderate to slight increases.
Looking ahead, expect further shifts influenced by healthcare advancements, aging populations, and increased awareness. Countries with higher year-on-year variations may continue to see changes in mortality due to socio-economic factors and healthcare infrastructure developments.
Top countries in Bladder Malignant Neoplasms Mortality Share by Country (Units (Deaths))
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 25.4 | 2023 | -0.066% | +0.12% | View data |
| 2 | 2 United Kingdom | 8.77 | 2023 | +0.82% | +1.16% | View data |
| 3 | 3 Germany | 8.68 | 2023 | -0.28% | +0.067% | View data |
| 4 | 4 Brazil | 7.66 | 2023 | +2.54% | +2.66% | View data |
| 5 | 5 Poland | 6.79 | 2023 | +2.19% | +2.42% | View data |
| 6 | 6 Spain | 6.74 | 2023 | -0.27% | +0.18% | View data |
| 7 | 7 Canada | 3.58 | 2023 | +1.11% | +0.46% | View data |
| 8 | 8 Romania | 2.64 | 2023 | +1.22% | +1.77% | View data |
| 9 | 9 South Korea | 2.57 | 2023 | +2.23% | +3.94% | View data |
| 10 | 10 Greece | 2.06 | 2023 | +1.04% | +1.33% | View data |
